Literature DB >> 16609807

CSF-air-exchange for pharmacorefractory status epilepticus.

Martin Köhrmann, Hagen B Huttner, Daniel Gotthardt, Simon Nagel, Christian Berger, Stefan Schwab.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16609807     DOI： 10.1007/s00415-006-0181-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Refractory status epilepticus in 2001.

Authors:  Thomas P Bleck
Journal:  Arch Neurol       Date:  2002-02

2.  [Experimental studies on Kojevnikoff's epilepsy].

Authors:  K SCHMALBACH; H W STEINMANN
Journal:  Acta Neurochir (Wien)       Date:  1958       Impact factor: 2.216

Review 3.  Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.

Authors:  Jan Claassen; Lawrence J Hirsch; Ronald G Emerson; Stephan A Mayer
Journal:  Epilepsia       Date:  2002-02       Impact factor: 5.864

4.  Refractory status epilepticus: frequency, risk factors, and impact on outcome.

Authors:  Stephan A Mayer; Jan Claassen; Johnny Lokin; Felicia Mendelsohn; Lyle J Dennis; Brian-Fred Fitzsimmons
Journal:  Arch Neurol       Date:  2002-02

5.  [On the recognition of epilepsia partialis continua (Kozhevnikov)].

Authors:  R W Heckl; J Schäfer
Journal:  Nervenarzt       Date:  1976-05       Impact factor: 1.214

6.  [Therapeutic problems in status epilepticus (author's transl)].

Authors:  K Pateisky; P Wessely
Journal:  Wien Klin Wochenschr       Date:  1976-03-05       Impact factor: 1.704
  6 in total
  2 in total

Review 1.  [Management of refractory and super-refractory status epilepticus].

Authors:  Frank Erbguth
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

Review 2.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.